94 related articles for article (PubMed ID: 10667375)
1. Five-lipoxygenase inhibitors reduce Panc-1 survival: synergism of MK886 with gamma linolenic acid.
Harris JE; Alrefai WA; Meng J; Anderson KM
Adv Exp Med Biol; 1999; 469():505-10. PubMed ID: 10667375
[No Abstract] [Full Text] [Related]
2. Five-lipoxygenase inhibitors reduce Panc-1 survival: the mode of cell death and synergism of MK886 with gamma linolenic acid.
Anderson KM; Seed T; Meng J; Ou D; Alrefai WA; Harris JE
Anticancer Res; 1998; 18(2A):791-800. PubMed ID: 9615721
[TBL] [Abstract][Full Text] [Related]
3. Modulation of cellular proliferation and induction of apoptosis in a human lymphoma cell line after treatment with selective lipoxygenase inhibitors.
Anderson KM; Ondrey FG; Harris JE
Adv Exp Med Biol; 1999; 469():563-8. PubMed ID: 10667383
[No Abstract] [Full Text] [Related]
4. Roles of 5-lipoxygenase activating protein in cell proliferation and apoptosis.
Wu X; Biswal SS; Kehrer JP
Cell Biol Toxicol; 2003 Jun; 19(3):135-43. PubMed ID: 12945742
[TBL] [Abstract][Full Text] [Related]
5. Increased cytosol Ca(2+) and type 1 programmed cell death in Bcl-2-positive U937 but not in Bcl-2-negative PC-3 and Panc-1 cells induced by the 5-lipoxygenase inhibitor MK 886.
Anderson KM; Alrefai WA; Dudeja PK; Jadko S; Bonomi P; Hu Y; Ou D; Harris JE
Prostaglandins Leukot Essent Fatty Acids; 2002 Apr; 66(4):443-52. PubMed ID: 12054916
[TBL] [Abstract][Full Text] [Related]
6. A relationship between 5-lipoxygenase-activating protein and bcl-xL expression in murine pro-B lymphocytic FL5.12 cells.
Datta K; Biswal SS; Xu J; Towndrow KM; Feng X; Kehrer JP
J Biol Chem; 1998 Oct; 273(43):28163-9. PubMed ID: 9774436
[TBL] [Abstract][Full Text] [Related]
7. 5-Lipoxygenase inhibitors reduce PC-3 cell proliferation and initiate nonnecrotic cell death.
Anderson KM; Seed T; Vos M; Mulshine J; Meng J; Alrefai W; Ou D; Harris JE
Prostate; 1998 Nov; 37(3):161-73. PubMed ID: 9792133
[TBL] [Abstract][Full Text] [Related]
8. Enhancing antitumor effects in pancreatic cancer cells by combined use of COX-2 and 5-LOX inhibitors.
Ding X; Zhu C; Qiang H; Zhou X; Zhou G
Biomed Pharmacother; 2011 Oct; 65(7):486-90. PubMed ID: 21993002
[TBL] [Abstract][Full Text] [Related]
9. Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells.
Ding XZ; Iversen P; Cluck MW; Knezetic JA; Adrian TE
Biochem Biophys Res Commun; 1999 Jul; 261(1):218-23. PubMed ID: 10405349
[TBL] [Abstract][Full Text] [Related]
10. Reversal of human neutrophil survival by leukotriene B(4) receptor blockade and 5-lipoxygenase and 5-lipoxygenase activating protein inhibitors.
Lee E; Lindo T; Jackson N; Meng-Choong L; Reynolds P; Hill A; Haswell M; Jackson S; Kilfeather S
Am J Respir Crit Care Med; 1999 Dec; 160(6):2079-85. PubMed ID: 10588632
[TBL] [Abstract][Full Text] [Related]
11. Reactive oxygen species and redox-induced programmed cell death due to MK 886: cells ("soil") "trump" agent ("seed").
Anderson KM; Rubenstein M; Alrefai WA; Dudeja P; Tsui P; Guinan P; Harris JE
In Vivo; 2005; 19(1):109-18. PubMed ID: 15796162
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of 5-lipoxygenase induces cell death in anti-inflammatory fatty acid-treated HL-60 cells.
Gillis RC; Daley BJ; Enderson BL; Karlstad MD
JPEN J Parenter Enteral Nutr; 2004; 28(5):308-14. PubMed ID: 15449569
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of vinculin upon MK886-induced apoptosis in LN18 glioblastoma cells.
Magro AM; Magro AD; Cunningham C; Miller MR
Neoplasma; 2007; 54(6):517-26. PubMed ID: 17949236
[TBL] [Abstract][Full Text] [Related]
14. Central role of arachidonate 5-lipoxygenase in the regulation of cell growth and apoptosis in human prostate cancer cells.
Ghosh J; Myers CE
Adv Exp Med Biol; 1999; 469():577-82. PubMed ID: 10667385
[No Abstract] [Full Text] [Related]
15. Toxicity of human monocytic THP-1 cells and microglia toward SH-SY5Y neuroblastoma cells is reduced by inhibitors of 5-lipoxygenase and its activating protein FLAP.
Klegeris A; McGeer PL
J Leukoc Biol; 2003 Mar; 73(3):369-78. PubMed ID: 12629151
[TBL] [Abstract][Full Text] [Related]
16. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
Hong SH; Avis I; Vos MD; MartÃnez A; Treston AM; Mulshine JL
Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
[TBL] [Abstract][Full Text] [Related]
17. The 5-lipoxygenase-activating protein (FLAP) inhibitor, MK886, induces apoptosis independently of FLAP.
Datta K; Biswal SS; Kehrer JP
Biochem J; 1999 Jun; 340 ( Pt 2)(Pt 2):371-5. PubMed ID: 10333477
[TBL] [Abstract][Full Text] [Related]
18. Altered oncogene, tumor suppressor and cell-cycle gene expression in PANC-1 cells cultured with the pleiotrophic 5-lipoxygenase inhibitor, MK886, assessed with a gene chip.
Anderson KM; Alrefai WA; Bonomi P; Dudeja P; Ou D; Anderson C; Harris JE
Anticancer Res; 1999; 19(5B):3873-87. PubMed ID: 10628326
[TBL] [Abstract][Full Text] [Related]
19. Effects of the 5-lipoxygenase activating protein inhibitor MK886 on voltage-gated and Ca2+-activated K+ currents in rat arterial myocytes.
Smirnov SV; Knock GA; Aaronson PI
Br J Pharmacol; 1998 Jun; 124(3):572-8. PubMed ID: 9647483
[TBL] [Abstract][Full Text] [Related]
20. Y-27632 Increases Sensitivity of PANC-1 Cells to EGCG in Regulating Cell Proliferation and Migration.
Liu X; Bi Y
Med Sci Monit; 2016 Oct; 22():3529-3534. PubMed ID: 27694793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
